| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |